Skip to main content
Premium Trial:

Request an Annual Quote

VWR to Distribute Axela's Protein Tools, Reagents in North America

NEW YORK (GenomeWeb News) – Lab supply vendor VWR will distribute Axela’s protein interaction instrument and associated reagents to North American customers under a new agreement, VWR said Tuesday.
Axela’s field scientists and territory managers will supply commercial and technical support for VWR’s efforts in marketing Axela’s dotLab system and reagents to clinical research and life sciences researchers, VWR said.
Axela CEO Rocky Ganske said the initial applications for the dotLab “are focused on accelerating the study of biomolecular interactions, optimizing protein expression, and the rapid development of quantitative immunoassays.”
Financial terms of the agreement were not released.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.